Case-control studies on venous thromboembolism: bias due to design? A methodological study on venous thromboembolism and steroid hormone use

被引:25
作者
Heinemann, LAJ [1 ]
Lewis, MA
Assmann, A
Thiel, C
机构
[1] ZEG, Ctr Epidemiol & Hlth Res Berlin, Berlin, Germany
[2] EPES Epidemiol Pharmacoepidemiol & Syst Res GmbH, Berlin, Germany
[3] Univ Kansas, Med Ctr, Dept Prevent Med, Kansas City, KS 66103 USA
[4] Univ Surrey, European Inst Hlth & Med Sci, Guildford GU2 5XH, Surrey, England
关键词
venous thromboembolism; steroid hormones; case-control study; methodological requirements; bias;
D O I
10.1016/S0010-7824(01)00309-2
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
This study addressed methodological issues of epidemiologic studies on venous thromboembolism (VTE) to show how design decisions can affect the results. It examines the influence of a restricting to hospitalized and to "idiopathic" cases of VTE in case-control studies on VTE risk and oral contraceptive (OC) use and thereby the bias potential. The diagnostic processes and OC exposures of 1068 suspected cases of VTE were followed in 21 German centers from 1994 to 1999 and evaluated compared to population and hospital controls. Of 606 confirmed cases, 385 (65.5%) were hospitalized, 168 (27.7%) were "idiopathic." Comparing users versus nonusers of OCs, the odds ratio (OR) for VTE risk for all cases and controls was 3.38 and 5.44 for "idiopathic" VTE. For hospital cases and controls, the OR was 3.72 and 9.1 for "idiopathic" VTE. The risk ratio for third- vs. second-generation OCs was increased in the hospital base but not in the population base. It was concluded that restriction to hospitalized events and exclusions of certain cases overestimate the VTE risk of OCs. An evidence-based consensus on methodological standards and definitions in case-control studies on VTE and steroid hormone use is required. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:207 / 214
页数:8
相关论文
共 13 条
[1]   Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias [J].
Bloemenkamp, KWM ;
Rosendaal, FP ;
Büller, HR ;
Helmerhorst, FM ;
Colly, LP ;
Vandenbroucke, JP .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (01) :65-70
[2]   Reproductive choices in 2000: The relative safety of current oral contraceptives - Preface [J].
Edwards, RG ;
Cohen, J .
HUMAN REPRODUCTION UPDATE, 1999, 5 (06) :563-564
[3]  
Heinemann L A, 2000, Eur J Contracept Reprod Health Care, V5, P183, DOI 10.1080/13625180008500392
[4]  
Heinemann LAJ, 1997, ORAL CONTRACEPTIVES AND CARDIOVASCULAR DISEASE, P19
[5]  
Heinemann LAJ, 1997, GYNAKOLOGE, V30, P296
[6]   The changing scene - an unnecessary pill crisis [J].
Heinemann, LAJ .
HUMAN REPRODUCTION UPDATE, 1999, 5 (06) :746-755
[7]   The epidemiology of oral contraceptive use: A critical review of the studies on oral contraceptives and the health of young women [J].
Lewis, MA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 179 (04) :1086-1097
[8]   The differential risk of oral contraceptives:: the impact of full exposure history [J].
Lewis, MA ;
MacRae, KD ;
Kühl-Habich, D ;
Bruppacher, R ;
Heinemann, LAJ ;
Spitzer, WO .
HUMAN REPRODUCTION, 1999, 14 (06) :1493-1499
[9]   The increased risk of venous thromboembolism and the use of third generation progestagens: Role of bias in observational research [J].
Lewis, MA ;
Heinemann, LAJ ;
MacRae, KD ;
Bruppacher, R ;
Spitzer, WO .
CONTRACEPTION, 1996, 54 (01) :5-13
[10]   Oral contraceptives and thrombotic diseases: Impact of new epidemiological studies [J].
Lidegaard, O ;
Milsom, I .
CONTRACEPTION, 1996, 53 (03) :135-139